Insulin-Dependent Regulation of mTORC2-Akt-FoxO Suppresses TLR4 Signaling in Human Leukocytes: Relevance to Type 2 Diabetes

Leukocyte signaling in patients with systemic insulin resistance is largely unexplored. We recently discovered the presence of multiple Toll-like receptor 4 (TLR4) signaling intermediates in leukocytes from patients with type 2 diabetes or acute insulin resistance associated with cardiopulmonary bypass surgery. We extend this work to show that in addition to matrix metalloproteinase 9, hypoxia-inducible factor 1α, and cleaved AMPKα, patient leukocytes also express IRS-1 phosphorylated on Ser312, Akt phosphorylated on Thr308, and elevated TLR4 expression. Similar signaling intermediates were detected in leukocytes and neutrophils treated with lipopolysaccharide (LPS), a ligand of TLR4, in vitro. In contrast, insulin, but not LPS, induced mammalian target of rapamycin complex 2 (mTORC2)–dependent phosphorylation of Akt on Ser473 and FoxO1/O3a on Thr24/32 in leukocytes and neutrophils. Insulin suppressed LPS-induced responses in a dose- and time-dependent manner. AS1842856, a FoxO1 inhibitor, also suppressed TLR4 signaling. We propose that insulin is a homeostatic regulator of leukocyte responses to LPS/TLR4 and that the signaling intermediates expressed in leukocytes of patients with type 2 diabetes indicate TLR4 signaling dominance and deficient insulin signaling. The data suggest that insulin suppresses LPS/TLR4 signals in leukocytes through the mTORC2-Akt-FoxO signaling axis. Better understanding of leukocyte signaling in patients with type 2 diabetes may shed new light on disease causation and progression.

[1]  Jeffrey L Carson,et al.  Proteolytic Cleavage of AMPKα and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1α Expression in Leukocytes , 2015, The Journal of Immunology.

[2]  S. Calvano,et al.  Cellular Metabolic Regulators: Novel Indicators of Low-Grade Inflammation in Humans , 2014, Annals of surgery.

[3]  Shaodong Guo.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. , 2014, The Journal of endocrinology.

[4]  H. Hansen,et al.  Comment on: Harte et al. High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects. Diabetes Care 2012;35:375–382 , 2013, Diabetes Care.

[5]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[6]  N. Al-Daghri,et al.  High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects , 2012, Diabetes Care.

[7]  G. Tzivion,et al.  FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. , 2011, Biochimica et biophysica acta.

[8]  J. Suttles,et al.  Mammalian Target of Rapamycin Complex 2 (mTORC2) Negatively Regulates Toll-like Receptor 4-mediated Inflammatory Response via FoxO1* , 2011, The Journal of Biological Chemistry.

[9]  I. Hers,et al.  mTORC2 Protein-mediated Protein Kinase B (Akt) Serine 473 Phosphorylation Is Not Required for Akt1 Activity in Human Platelets* , 2011, The Journal of Biological Chemistry.

[10]  E. E. Vincent,et al.  Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer , 2011, British Journal of Cancer.

[11]  S. Tangye,et al.  Inflammatory Mechanisms in Obesity , 2013 .

[12]  V. Salomaa,et al.  Endotoxemia Is Associated With an Increased Risk of Incident Diabetes , 2011, Diabetes Care.

[13]  C. Glass,et al.  FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages , 2010, The EMBO journal.

[14]  T. Shimokawa,et al.  Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice , 2010, Molecular Pharmacology.

[15]  Stephen F. Lowry,et al.  Roles of SIRT1 in the Acute and Restorative Phases following Induction of Inflammation* , 2010, The Journal of Biological Chemistry.

[16]  P. Dandona,et al.  Insulin Suppresses Endotoxin-Induced Oxidative, Nitrosative, and Inflammatory Stress in Humans , 2010, Diabetes Care.

[17]  S. Devaraj,et al.  Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects , 2010, Diabetes Care.

[18]  I. Verma,et al.  Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. , 2009, Cell metabolism.

[19]  Yi Lu,et al.  FoxO1 Links Insulin Resistance to Proinflammatory Cytokine IL-1β Production in Macrophages , 2009, Diabetes.

[20]  D. Sabatini,et al.  An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.

[21]  R. DeFronzo,et al.  Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects , 2008, Diabetes.

[22]  Katerina Akassoglou,et al.  NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α , 2008, Nature.

[23]  S. Peng,et al.  Foxo in the immune system , 2008, Oncogene.

[24]  D. Webb,et al.  A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. , 2007, The American journal of clinical nutrition.

[25]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[26]  B. Kemp,et al.  AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling , 2007, Circulation research.

[27]  S. Armstrong,et al.  FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.

[28]  R. DePinho,et al.  FoxO4 Regulates Tumor Necrosis Factor Alpha-Directed Smooth Muscle Cell Migration by Activating Matrix Metalloproteinase 9 Gene Transcription , 2007, Molecular and Cellular Biology.

[29]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[30]  S. Walrand,et al.  Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans. , 2006, The Journal of clinical endocrinology and metabolism.

[31]  S. Lowry,et al.  HUMAN ENDOTOXEMIA: A MODEL FOR MECHANISTIC INSIGHT AND THERAPEUTIC TARGETING , 2005, Shock.

[32]  M. Borger,et al.  Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. , 2005, The Journal of thoracic and cardiovascular surgery.

[33]  P. Allen,et al.  Inflammatory arthritis requires Foxo3a to prevent Fas ligand–induced neutrophil apoptosis , 2005, Nature Medicine.

[34]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[35]  R. Loewith,et al.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.

[36]  R. Gaynor,et al.  IκB kinases: key regulators of the NF-κB pathway , 2004 .

[37]  L. Crossley,et al.  Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl‐1 , 2003, Journal of leukocyte biology.

[38]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[39]  R. Jaenisch,et al.  HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.

[40]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[41]  R. Little,et al.  Insulin resistance and substrate utilization in human endotoxemia. , 2000, The Journal of clinical endocrinology and metabolism.

[42]  T. Hunter,et al.  Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[44]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[45]  P. Ernsberger,et al.  Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. , 1997, American journal of physiology. Endocrinology and metabolism.

[46]  G. Thomas,et al.  The modular phosphorylation and activation of p70s6k , 1997, FEBS letters.

[47]  P. Cohen,et al.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.

[48]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[49]  R. Pearson,et al.  The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. , 1995, The EMBO journal.

[50]  R. Wolfe,et al.  Mechanisms of Insulin Resistance Following Injury , 1982, Annals of surgery.

[51]  L. Amorosa,et al.  Proteolytic Cleavage of AMPKa and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1a Expression in Leukocytes , 2015 .

[52]  C. Kahn,et al.  Insulin receptor signaling in normal and insulin-resistant states. , 2014, Cold Spring Harbor perspectives in biology.

[53]  Neil R. Powe,et al.  The Atherosclerosis Risk in Communities Study , 2006 .

[54]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[55]  R. Gaynor,et al.  IkappaB kinases: key regulators of the NF-kappaB pathway. , 2004, Trends in biochemical sciences.

[56]  R. Jaenisch,et al.  HIF-1alpha is essential for myeloid cell-mediated inflammation. , 2003, Cell.